EDSA
Edesa Biotech Inc
NASDAQ: EDSA · HEALTHCARE · BIOTECHNOLOGY
$18.28
+14.94% today
Updated 2026-04-30
Market cap
$64.51M
P/E ratio
—
P/S ratio
130,462.29x
EPS (TTM)
$-1.07
Dividend yield
—
52W range
$1 – $12
Volume
5.6M
Edesa Biotech Inc (EDSA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+25.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+41.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-7.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-17.5%
2025-12-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-13 | $-0.28 | +9.7% | $1.00 | $1.03 | +2.5% |
| 2025-12-12 | $-0.32 | +42.9% | $1.77 | $1.46 | -17.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.31 | $-0.28 | +9.7% | — | — |
| 2025-09-30 | $-0.56 | $-0.32 | +42.9% | — | — |
| 2025-06-30 | $-0.50 | $-0.25 | +50.0% | — | — |
| 2025-03-31 | $-0.30 | $-0.30 | -1.7% | — | — |
| 2024-12-31 | $-0.31 | $-0.48 | -54.8% | — | — |
| 2024-09-30 | $-0.54 | $-0.29 | +46.3% | — | — |
| 2024-06-30 | $-0.58 | $-0.52 | +10.3% | — | — |
| 2024-03-31 | $-0.69 | $-0.58 | +15.9% | — | — |
| 2023-12-31 | $-1.21 | $-0.54 | +55.4% | — | — |
| 2023-09-30 | $-0.71 | $-0.60 | +15.5% | $-1.12M | — |
| 2023-06-30 | $-0.17 | $-0.10 | +41.2% | — | — |
| 2023-03-31 | $-0.17 | $-0.12 | +29.4% | — | — |
Frequently asked questions
Has Edesa Biotech Inc beaten earnings estimates?
Edesa Biotech Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +25.2% over the last 4 quarters.
How does EDSA stock react to earnings?
EDSA stock has moved an average of -7.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.